← All organizations

Humacyte, Inc.

For profitContributed to NMEWebsite ↗

Also known as: Humacyte Global Inc. | Humacyte, Inc.

Highest phase reached

Phase 3

First clinical trial

May 24, 2016

First marketed drug

Dec 19, 2024

First NDA

Dec 19, 2024

Last known activity

Dec 19, 2024

Timeline

2000s

  1. Jan 1, 2004

    Humacyte, Inc.— Founded

2020s

  1. Dec 19, 2024

    acellular tissue engineered vessel— NDA Organization

Drugs by trial phase (1 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (11)

Details

Founded
Durham, NC, US Jan 1, 2004
First NDA
Dec 19, 2024
Last known activity
Dec 19, 2024